Global Cancer Biomarkers Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Market Overview:

The global Cancer Biomarkers Marketwas valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.
Cancer Biomarkers have high usage in Cancer diagnostics and treatment, especially in Tissue specific therapies. Therefore market of this genetically engineered product is seeing high values in terms of market value.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Increasing Technological Developments
1.2 Growingnumber of cancer Patients and usage of biomarkers
1.3 Increasing research in biomarkers
2. Market Restraints
2.1 Reimbursements Risks
2.2 High investment and uncertainty of favorable profits
2.3 Technicality concerns

Market Segmentation:
1. Global Cancer Biomarkers Market, by Application:
1.1 Diagnostics
1.2 Research and Development
1.3 Prognostics
1.4 Risk Assessment
1.5 Other Applications

2. Global Cancer Biomarkers Market, by Cancer Type:
2.1 Breast Cancer
2.2 Lung Cancer
2.3 Colorectal Cancer
2.4 Prostate Cancer
2.5 Non-Hodgkin’s Lymphoma
2.6 Melanoma
2.7 Leukemia
2.8 Thyroid Cancer
2.9 Bladder Cancer
2.10 Kidney Cance
2.11 Other Cancer Types

3. Global Cancer Biomarkers Market, by Profiling Technology:
3.1 Omics Technologies
3.1.1 Proteomics
3.1.2 Genomics
3.1.2.1 Next-Generation Sequencing (NGS)
3.1.2.2 Polymerase Chain Reaction (PCR)
3.1.3 Other Omics Technologies
3.2 Imaging Technologies
3.2.1 Ultrasound
3.2.2 Computed Tomography (Ct)
3.2.3 Magnetic Resonance Imaging (Mri)
3.2.4 Positron Emission Tomography (Pet)
3.2.5 Mammography
3.3 Immunoassays
3.4 Cytogenetics
3.4.1 in Situ Hybridization (Ish)
3.4.2 Other Cytogenetics-Based Tests
3.5 Bioinformatics

4. Global Cancer Biomarkers Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Qiagen N.V.
5. Illumina
6. GE Healthcare
7. Agilent Technologies
8. Biomérieux SA
9. Merck & Co.
10. Abbott Laboratories
11. Becton, Dickinson and Company
12. Danaher Corporation
13. Myriad Genetics
14. Sysmex Corporation
15. Hologic
16. Quest Diagnostics

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cancer Biomarkers Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL CANCER BIOMARKERS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CANCER BIOMARKERS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION
5.1 Diagnostics
5.2 Research and Development
5.3 Prognostics
5.4 Risk Assessment
5.5 Other Applications

6 GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE
6.1 Breast Cancer
6.2 Lung Cancer
6.3 Colorectal Cancer
6.4 Prostate Cancer
6.5 Non-Hodgkin’s Lymphoma
6.6 Melanoma
6.7 Leukemia
6.8 Thyroid Cancer
6.9 Bladder Cancer
6.10 Kidney Cancer
6.11 Other Cancer Types

7 GLOBAL CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY
7.1 Omics Technologies
7.1.1 Proteomics
7.1.2 Genomics
7.1.3 Other Omics Technologies

7.2 Imaging Technologies
7.2.1 Ultrasound
7.2.2 Computed Tomography (Ct)
7.2.3 Magnetic Resonance Imaging (Mri)
7.2.4 Positron Emission Tomography (Pet)
7.2.5 Mammography

7.3 Immunoassays

7.4 Cytogenetics
7.4.1 in Situ Hybridization (Ish)
7.4.2 Other Cytogenetics-Based Tests
7.5 Bioinformatics

8 GLOBAL CANCER BIOMARKERS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL CANCER BIOMARKERS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Thermo Fisher Scientific
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Bio-Rad Laboratories
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Roche Diagnostics
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Qiagen N.V.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Illumina
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 GE Healthcare
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Agilent Technologies
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Biomérieux SA
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Merck & Co.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Abbott Laboratories
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Becton, Dickinson and Company
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Danaher Corporation
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Myriad Genetics
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Sysmex Corporation
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

10.15 Hologic
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments

11 Appendix
11.1 Related Reports
Medical Devices

Global Bile Duct Cancer Drug Market Research Report 2020 (Covid-19 Version)

  Price : US$ 3,500   Date : Jan 1970
  Category : Medical Devices   Pages : 152
Medical Devices

Global Targeted Cancer Drugs Market Research Report 2020 (Covid-19 Version)

  Price : US$ 3,500   Date : Jan 1970
  Category : Medical Devices   Pages : 112
Medical Devices

Global Cancer Stem Cells (CSCs) Market Research Report 2020 (Covid-19 Version)

  Price : US$ 3,500   Date : Jan 1970
  Category : Medical Devices   Pages : 175
Medical Devices

Global Pet Cancer Therapeutics Market Research Report 2020 (Covid-19 Version)

  Price : US$ 3,500   Date : Jan 1970
  Category : Medical Devices   Pages : 132

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2020 Worldwide Market Reports. All rights reserved